Literature DB >> 6166558

Monoclonal antibodies to stage-specific, species-specific, and cross-reactive antigens of the rodent malarial parasite, Plasmodium yoelii.

D W Taylor, K J Kim, P A Munoz, C B Evans, R Asofsky.   

Abstract

Eighteen hybridoma cell lines were used to study species-specific, stage-specific, and serological cross-reactive antigens of the rodent malarial parasite, Plasmodium yoelii. Specificity and location of plasmodial antigens were determined by indirect fluorescent-antibody analysis. Results showed that a minimum of 12 distinct plasmodial antigens could be distinguished by the 18 hybridomas. Antigens were found on the surface or within the cytoplasm of the parasite, but not on the surface of erythrocytes from infected animals. The majority (11 of 12) of antigens were present in all erythrocytic stages of the parasite, but one was stage-specific for merozoites. Additional studies showed that 6 of 18 of the monoclonal antibodies identified species-specific antigens, 2 of 18 recognized antigens confined to related rodent malarial parasites (Plasmodium berghei, Plasmodium vinckei, and Plasmodium chabaudi), whereas 8 of 18 detected cross-reactive antigens common to rodent, primate (Plasmodium knowlesi, Plasmodium falciparum), and avian (Plasmodium gallinaceum) malarias.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166558      PMCID: PMC351484          DOI: 10.1128/iai.32.2.563-570.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Fluorescent antibody studies on cross reactions between human and simian malaria in normal volunteers.

Authors:  J E TOBIE; S F KUVIN; P G CONTACOS; G R COATNEY; C B EVANS
Journal:  Am J Trop Med Hyg       Date:  1962-09       Impact factor: 2.345

2.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

3.  Plasmodium gallinaceum as antigen in immunofluorescence antibody studies.

Authors:  A Kielmann; N Weiss
Journal:  Acta Trop       Date:  1968       Impact factor: 3.112

4.  Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite.

Authors:  N Yoshida; R S Nussenzweig; P Potocnjak; V Nussenzweig; M Aikawa
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

5.  An in vitro assay for T cell immunity to malaria in mice.

Authors:  F I Weinbaum; C B Evans; R E Tigelaar
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

6.  Fine structure of human malaria in vitro.

Authors:  S G Langreth; J B Jensen; R T Reese; W Trager
Journal:  J Protozool       Date:  1978-11

7.  Malaria (Plasmodium knowlesi) merozoites: immunity and the surface coat.

Authors:  L H Miller; M Aikawa; J A Dvorak
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

8.  Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite.

Authors:  R R Freeman; A J Trejdosiewicz; G A Cross
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

9.  Antigenicity of the infected-erythrocyte and merozoite surfaces in Falciparum malaria.

Authors:  S G Langreth; R T Reese
Journal:  J Exp Med       Date:  1979-11-01       Impact factor: 14.307

10.  Two Plasmodium knowlesi-specific antigens on the surface of schizont-infected Rhesus monkey erythrocytes induce antibody production in immune hosts.

Authors:  R Schmidt-Ullrich; D F Wallach; J Lightholder
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Monoclonal antibodies against microorganisms.

Authors:  R A Polin
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

2.  Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.

Authors:  P Ray; N Sahoo; B Singh; F A Kironde
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

3.  Stage-specific and species-specific antigens of Plasmodium vivax and Plasmodium ovale defined by monoclonal antibodies.

Authors:  P M Andrysiak; W E Collins; G H Campbell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

4.  Studies of murine malaria antigens using monoclonal antibodies. Production, selection, and characterization of antibodies.

Authors:  G Holmquist; P Borwell; A R Cattan; H Wigzell
Journal:  Z Parasitenkd       Date:  1986

5.  Use of a two-sited monoclonal antibody assay to detect a heat-stable malarial antigen in the sera of mice infected with Plasmodium yoelii.

Authors:  D W Taylor; C B Evans; G W Hennessy; S B Aley
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

6.  Monoclonal antibodies that protect in vivo against Plasmodium chabaudi recognize a 250,000-dalton parasite polypeptide.

Authors:  D B Boyle; C I Newbold; C C Smith; K N Brown
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

7.  Immunoelectrophoretic analysis of erythrocytic stages of Plasmodium yoelii and P. chabaudi.

Authors:  J Carlsson; K Berzins; P Perlmann
Journal:  Z Parasitenkd       Date:  1984

8.  In silico epitope mapping and experimental evaluation of the Merozoite Adhesive Erythrocytic Binding Protein (MAEBL) as a malaria vaccine candidate.

Authors:  Pedro Cravo; Renato B Machado; Juliana A Leite; Taizy Leda; Rossarin Suwanarusk; Najara Bittencourt; Letusa Albrecht; Carla Judice; Stefanie C P Lopes; Marcus V G Lacerda; Marcelo U Ferreira; Irene S Soares; Yun Shan Goh; Daniel Y Bargieri; François Nosten; Bruce Russell; Laurent Rénia; Fabio T M Costa
Journal:  Malar J       Date:  2018-01-10       Impact factor: 2.979

9.  Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours.

Authors:  Ricardo Coelho; Lara Marcos-Silva; Nuno Mendes; Daniela Pereira; Catarina Brito; Francis Jacob; Catharina Steentoft; Ulla Mandel; Henrik Clausen; Leonor David; Sara Ricardo
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.